Vol 4, No 4 (December 26, 2013): Journal of Gastrointestinal Oncology

Intensifying local radiotherapy for pancreatic cancer—who benefits and how do we select them?

New possibilities and potential benefits for local control in locally recurrent pancreatic cancer

Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions

Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer

Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma

Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers

Neoadjuvant hyperfractionated-accelerated radiotherapy with concomitant chemotherapy in esophageal cancer: phase II study

Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study

Mismatch repair protein expression in colorectal cancer

Diet and supplements and their impact on colorectal cancer

A case report of trastuzumab dose in gastric cancer

Intrapancreatic accessory spleen presenting as a pancreatic mass

Metachronous pancreatic metastasis of an ovarian serous papillary adenocarcinoma after 8 years

Cholangiocarcinoma: treatment with sorafenib extended life expectancy to greater than four years

RE: Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only).